Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and possible divestitures.
Latest Ratings for MDT
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Credit Suisse | Maintains | Outperform | |
| Feb 2022 | Needham | Maintains | Buy | |
| Feb 2022 | Raymond James | Maintains | Outperform |
